A Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Subjects With Binge Eating Disorder
Trial details
- Registry ID
- NCT06878976
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Subjects With Binge Eating DisorderNCT06878976 | AXSM | Phase 3 | Enrolling by invitation | 2027-12Estimated |
| An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHDNCT07773883 | AXSM | Phase 3 | Enrolling by invitation | 2027-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |